Last update:

Oncology news

New findings link obesity to loss of natural breast cancer protection

A research team at Huntsman Cancer Institute at the University of Utah (the U) has found that obesity prevents a biological process that kills cancerous cells, revealing a possible reason obesity is a risk factor for breast ...

New 'smart' nanoparticles help the immune system better attack tumors

Adelaide University researchers have developed a new way to use mRNA technology to reprogram tumor-supporting immune cells and strengthen the body's anticancer immune response.

Protein linked to cell death may also drive liver cancer

New research from the University of Oklahoma identifies a protein in liver cells that appears to help drive the development of liver cancer associated with obesity-related fatty liver disease. The finding, published in Hepatology, ...

Child cancer groups call for concerted action

It's one of the cruelest ironies in health and medicine. Pediatric sarcomas are among the rarest yet most aggressive forms of childhood cancer and some of the hardest to cure. Whereas many adult cancers are now treatable ...

Mini-tumors reveal new drug combinations for liver cancer

Liver cancer is difficult to treat because tumors vary greatly from patient to patient. Researchers at the University of Basel have captured this diversity by creating a collection of mini-tumors, which they use to systematically ...

Supplement plus chemotherapy boosts pancreatic cancer survival

When added to standard chemotherapy, a clinical version of the dietary supplement L-glutamine improved survival in an early-phase trial of patients with advanced pancreatic cancer. The study, led by Cedars-Sinai Health Sciences ...

How melanoma silences the skin's natural antitumor defense

Cancers actively remodel their surrounding cells and tissues to create a microenvironment that favors their growth, survival and spread. Melanoma, a cancer of the pigment-producing melanocytes of the skin, is one of the most ...

Protein buildup may shape cancer drug response

The way cancer-causing proteins accumulate in tumors may influence how effectively a promising new generation of medicines can remove them, a study suggests. Researchers found that PROTAC (Proteolysis Targeting Chimeras) ...